The Enterprise Value as of June 2026 (TTM) for WuXi Biologics (Cayman) Inc. (WXIBF) is 100.50B

According to WuXi Biologics (Cayman) Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 100.50B. This represents a change of 28.05% compared to the average of 78.48B of the last 4 quarters.

WuXi Biologics (Cayman) Inc. (WXIBF) Historical Enterprise Value (quarterly & annually)

How has WXIBF Enterprise Value performed in the past?

The mean historical Enterprise Value of WuXi Biologics (Cayman) Inc. over the last ten years is 141.91B. The current 100.50B Enterprise Value has changed 6.98% with respect to the historical average. Over the past ten years (40 quarters), WXIBF's Enterprise Value was at its highest in in the June 2021 quarter at 512.04B. The Enterprise Value was at its lowest in in the January 2014 quarter at 0.

WuXi Biologics (Cayman) Inc. (WXIBF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of WuXi Biologics (Cayman) Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

WuXi Biologics (Cayman) Inc. (WXIBF) Average Enterprise Value

How has WXIBF Enterprise Value performed in the past?

The current Enterprise Value of WuXi Biologics (Cayman) Inc. (WXIBF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

WuXi Biologics (Cayman) Inc. (WXIBF) Enterprise Value vs. Peers

How is WXIBF’s Enterprise Value compared to its peers?

WuXi Biologics (Cayman) Inc.’s Enterprise Value is greater than Sino Biopharmaceutical Limited (79.40B), greater than Genmab A/S (19.29B), greater than Innovent Biologics, Inc. (97.37B), greater than Sino Biopharmaceutical Limited (79.40B), greater than Straumann Holding AG (16.65B), less than Astellas Pharma Inc. (4.10T), greater than bioMérieux S.A. (7.89B), greater than Straumann Holding AG (16.65B), greater than Orion Oyj (9.73B), less than Astellas Pharma Inc. (4.10T),

Build a custom stock screener for WuXi Biologics (Cayman) Inc. (WXIBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like WuXi Biologics (Cayman) Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

WuXi Biologics (Cayman) Inc. (WXIBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like WuXi Biologics (Cayman) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.